Morgan Keegan Arbitration Losses Could Exceed $200 Million

Over 1,000 investors have filed FINRA arbitration cases against Morgan Keegan to recover losses suffered in a number of bond funds managed by the regional brokerage firm, some of which have lost up to 95% of their value since mid-2007. According to Investment News, Morgan Keegan could ultimately end up paying over $200 million to resolve these cases.

The Morgan Keegan arbitration claims allege that investors were not properly informed about the risk associated with the firm’s bond funds, and the extent to which the funds were invested in risky mortgage backed securities, primarily involving the subprime mortgage market which began to collapse in late 2007.

The Morgan Keegan bond funds, such as RMK Select High Income Fund, RMK Select Intermediate Bond Fund, RMK High Income Fund, RMK Multi-Sector High Income Fund, RMK Advantage Income Fund and RMK Strategic Income Fund, were sold to investors as relatively conservative investment options. However, the arbitration claims allege that the fund managers violated the objectives outlined in the prospectuses, and exposed investors to a level of risk which they would not have agreed to accept if they had been fully informed of the circumstances surrounding the assets held by the funds.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Although several Morgan Keegan class action lawsuits have been filed on behalf of all investors who purchased or acquired shares in the mutual funds, most investors are electing to pursue their claims as individual arbitration claims through the Financial Industry Regulatory Authority (FINRA). In most cases, lawyers expect these Morgan Keegan arbitration claims to be heard within 12 to 18 months, while the class action lawsuits could take years to resolve.

FINRA oversees nearly 5,000 brokerage firms throughout the United States, and most broker agreements require that individual disputes between investors and their brokers be resolved through FINRA arbitration. The securities arbitration panels are generally comprised of attorneys, accountants, retired judges, bankers, brokers and other professionals, but usually one one of them is considered an “industry” person.

The first Morgan Keegan arbitration award stemming from the losses associated with the crash of the subprime mortgage market last year was returned by a FINRA panel in August, 2008. The claim was filed on January 14, 2008, and the investor was awarded over 75% of his claimed investment losses.

A wave of arbitration claims against Morgan Keegan are expected to reach hearings later this year, with the rest currently scheduled for early 2009.

1 Comments

  • Morgan Keegan Losses Awarded by FINRA Arbitration Panels - AboutLawsuits.comMarch 17, 2009 at 3:03 pm

    [...] has been estimated that Morgan Keegan settlements and arbitration awards may eventually exceed more than $200 [...]

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.